SBIR-STTR Award

Development of a nasal compression device with medicated intranasal sponges for the treatment of nosebleeds in any setting
Award last edited on: 3/3/2023

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$256,000
Award Phase
1
Solicitation Topic Code
MD
Principal Investigator
Elizabeth Clayborne

Company Information

Emergency Medical Innovation LLC

7825 Browns Bridge Road
Highland, MD 20777
   (919) 672-3730
   N/A
   N/A
Location: Single
Congr. District: 03
County: Howard

Phase I

Contract Number: 2136297
Start Date: 3/1/2022    Completed: 7/31/2023
Phase I year
2022
Phase I Amount
$256,000
This Small Business Innovation Research (SBIR) Phase I project is to help treat the common nosebleed. Nosebleeds are a common problem that 60% of people experience. The proposed project develops an effective and low-cost innovative technology to address this by combining external pressure with intranasal medication when placed in a nominal manner by any user. The solution would provide a simple method that reduces the need for patients to visit health care services, and reduces the burden of health care providers for treating nosebleeds. The goal of this project is to design and develop an effective nosebleed treatment device for children and adults that combines external pressure using a prototype nasal clip with intranasal medication sponges. The objectives of this project include completing systematic studies towards (1) design and development of a nasal clip with pre-medicated intranasal sponges capable of consistently applying the proper amount of pressure and eluting the proper amount of medication when placed in a nominal manner, (2) testing of the device using a nosebleed model, (3) identifying manufacturing processes to commercialize and scale the device in a cost effective manner. The outcome will be a functional and lab tested nosebleed treatment clip.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----